Palvella Therapeutics raises $3M to advance rare disease drug
Palvella Therapeutics, a Wayne-based biopharmaceutical company developing treatments for rare disease, has raised $3.4 million in an equity financing deal. The private stock sale was disclosed in documents the company filed with the Securities and Exchange Commission. The identity of the investors was not disclosed. The equity financing deal comes about four months after Palvella entered